StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) operating KPIs

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)

Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%

Thermo Fisher Scientific phân khúc Laboratory Products and Biopharma Services (Tổng doanh thu phân khúc) ($M)

Bao gồm 4 mảng vận hành: Pharma Services (Patheon CDMO), Clinical Research (PPD CRO), Research & Safety Market Channel (Fisher Scientific) và Laboratory Products.

QuarterlyAnnual
Latest, Q3 2026
6,863
Period ended Sep 30, 2026
Change on a year earlier
+15.0%
5,970 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
7
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPhân khúc Laboratory Products and Biopharma Services (Tổng doanh thu phân khúc) ($M)Year on yearSource
Q3 2026Sep 30, 20266,863+15.0%Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20266,693+11.6%Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 20266,036+7.0%Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20256,379+7.5%Q3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20255,970+4.0%Q3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 20255,995+4.1%Q3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 20255,640-1.5%Q3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20245,936+3.8%Q4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20245,740+0.2%Q4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 20245,758-1.3%Q4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 20245,723-0.7%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20235,719-3.8%Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20235,728+2.6%Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 20235,831+5.3%Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 20235,763+5.9%Q4 & FY2024 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 20225,947–SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗

Breakdown

What makes up phân khúc laboratory products and biopharma services (tổng doanh thu phân khúc)

Cite this data

StockData. (2026). Thermo Fisher Scientific Phân khúc Laboratory Products and Biopharma Services (Tổng doanh thu phân khúc) ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev_seg_lpbs

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.